Medicare patients are not at greater risk for cardiovascular disease (CVD) when taking anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) for migraines, compared with onabotulinumtoxinA treatment, shows a cohort study.

Low-risk, trial-like patients undergoing SAVR during the trial enrollment period have similar 30-day rates of mortality, but lower rates of stroke, compared with patients in the SAVR arm of the PARTNER 3 and Evolut Low Risk trials, a cross-sectional analysis shows. 

Incident hypertension and hypertension-related outcomes can be predicted by an artificial intelligence-enhanced electrocardiography (AI-ECG) model, AI-ECG risk estimator to predict incident hypertension, results from a cohort study show. 

Redo transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 (S3) valve presents challenges, according to a new analysis of patient data that also shows downsizing is frequent, and under-expansion may lead to suboptimal hemodynamics. 

New study findings challenge established practices in transcatheter aortic valve replacement (TAVR), as researchers demonstrate that transradial secondary access (TR-SA) significantly reduces complications compared to traditional transfemoral secondary access (TF-SA).  

A first-in-human study has demonstrated the exceptional safety and efficacy of the Magenta Elevate mechanical circulatory support (MCS) device during high-risk percutaneous coronary interventions (HR-PCI) involving the left main coronary artery (LM). 

Angiography-based physiological assessments can offer additional prognostic insights for patients undergoing intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI), according to a post-hoc analysis of the FLAVOUR trial. 

A new machine learning assessment of the ECLS-SHOCK study found there is a “low likelihood” that any subpopulation of infarct-related cardiogenic shock (CS) patients will respond to extracorporeal life support (ECLS). 

Cardiac rhythm monitoring after stroke continues to be a topic of debate as improved monitoring strategies increase likelihood of arrhythmia detection post-stroke, but impacts on secondary stroke prevention are still unclear, reports an expert consensus.